Tradestie Institutional Equity Comparison Engine
EVMN vs SION โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EVMN Overall Edge
EVMN Captures Institutional Edge (2โ1 Pillars ยท 2โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Momentum & Technical, Options & Structure while SION counters with relative strength in Growth & Margin. Fundamentally, EVMN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SION at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro) against SION sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
EVMN N/M vs SION N/M Fwd P/E
Growth & Margin Winner
SION
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
EVMN
1Y -61.0% vs -91.3% ยท 52W Pos 8% vs 0%
Options & Structure Winner
EVMN
SURGE (53rd %ile IV) vs BREAKDOWN (10th %ile IV)
EVMN
US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap
$315.5M
1M Return
+37.33%
1Y Return
-61.03%
Forward P/E
N/M
Unified AI Score
30.0 / 100
SELL
Tech 50.0
Fund 35.0
Flow 69.0
Mom 44.0
SION
NASDAQ
Sionna Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.12
-6.31% 1D
Market Cap
$150.6M
1M Return
-19.79%
1Y Return
-91.3%
Forward P/E
N/M
Unified AI Score
45.6 / 100
HOLD
Tech 34.0
Fund 50.0
Flow 67.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EVMN -61.03%
SION -91.3%
Spread: +30.27 pp (EVMN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EVMN TTM Op. Margin: 0.0%
SION TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVMN vs SION. Trailing 12-month operating profitability (EVMN 0.0% vs SION 0.0%) and valuation multiples (EVMN N/M vs SION N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EVMN | SION | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $315.5M | $150.6M | Larger Scale | EVMN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -69.5% | -39.0% | Higher ROE | SION |
| 52-Week Range Position Momentum | 8% ($5โ$33) | 0% ($3โ$55) | Stronger Trend | EVMN |
| Beta / 30D Volatility Risk Regime | 1.05ฮฒ ยท 118% Vol | 1.97ฮฒ ยท 78% Vol | Lower Realized Risk | SION |
| Unified Institutional Score Composite Signal | 30.0 / 100 (SELL) | 45.6 / 100 (HOLD) | Higher Composite | SION |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EVMN vs SION Buy Guide
EVMN
SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
53rd %ile
IV Regime
Balanced (25thโ60th %ile)
SION
BREAKDOWN
45d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EVMN nor SION registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.